167 related articles for article (PubMed ID: 24054875)
1. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.
Atalar B; Modlin LA; Choi CY; Adler JR; Gibbs IC; Chang SD; Harsh GR; Li G; Nagpal S; Hanlon A; Soltys SG
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):713-8. PubMed ID: 24054875
[TBL] [Abstract][Full Text] [Related]
2. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
Bilger A; Bretzinger E; Fennell J; Nieder C; Lorenz H; Oehlke O; Grosu AL; Specht HM; Combs SE
Cancer Med; 2018 Jun; 7(6):2350-2359. PubMed ID: 29745035
[TBL] [Abstract][Full Text] [Related]
3. Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.
Prabhu RS; Miller KR; Asher AL; Heinzerling JH; Moeller BJ; Lankford SP; McCammon RJ; Fasola CE; Patel KR; Press RH; Sumrall AL; Ward MC; Burri SH
J Neurosurg; 2018 Dec; 131(5):1387-1394. PubMed ID: 30554174
[TBL] [Abstract][Full Text] [Related]
4. Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02).
Phillips C; Pinkham MB; Moore A; Sia J; Jeffree RL; Khasraw M; Kam A; Bressel M; Haworth A
Breast; 2024 Apr; 74():103675. PubMed ID: 38340685
[TBL] [Abstract][Full Text] [Related]
5. Identification of risk factors associated with leptomeningeal disease after resection of brain metastases.
Morshed RA; Saggi S; Cummins DD; Molinaro AM; Young JS; Viner JA; Villanueva-Meyer JE; Goldschmidt E; Boreta L; Braunstein SE; Chang EF; McDermott MW; Berger MS; Theodosopoulos PV; Hervey-Jumper SL; Aghi MK; Daras M
J Neurosurg; 2023 Aug; 139(2):402-413. PubMed ID: 36640095
[TBL] [Abstract][Full Text] [Related]
6. DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer.
Borm KJ; Behzadi ST; Hörner-Rieber J; Krug D; Baumann R; Corradini S; Duma MN; Dunst J; Fastner G; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Matuschek C; Piroth MD; Schmeel LC; Souchon R; Strnad V; Budach W; Combs SE;
Strahlenther Onkol; 2024 Apr; 200(4):259-275. PubMed ID: 38488902
[TBL] [Abstract][Full Text] [Related]
7. Rate of pachymeningeal failure following adjuvant WBRT vs SRS in patients with brain metastases.
Gutierrez-Valencia E; Kalyvas A; Jamora K; Yang K; Lau R; Khan B; Millar BA; Laperriere N; Conrad T; Berlin A; Weiss J; Li X; Zadeh G; Bernstein M; Kongkham P; Shultz DB
Clin Transl Radiat Oncol; 2024 Mar; 45():100723. PubMed ID: 38282910
[TBL] [Abstract][Full Text] [Related]
8. Preoperative stereotactic radiosurgery for cerebral metastases: safe, effective, and decreases steroid dependency.
Mallela AN; Iheagwara UK; Fogg D; Anthony A; Gersey ZC; Zhang X; Abou-Al-Shaar H; Anand SK; Xu E; Zinn PO; Burton S; Quinn A; Ozhasoglu C; Clump DA; Siddiqui Z; Amankulor NM
J Neurosurg; 2024 May; ():1-11. PubMed ID: 38728761
[TBL] [Abstract][Full Text] [Related]
9. Systemic Treatment for Brain Metastasis and Leptomeningeal Disease in Breast Cancer Patients.
Puri S; Chaudhry A; Bayable A; Ganesh A; Daher A; Gadi VK; Maraka S
Curr Oncol Rep; 2023 Dec; 25(12):1419-1430. PubMed ID: 37924439
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective review.
Wallace G; Kundalia R; Vallebuona E; Cao B; Kim Y; Forsyth P; Soyano A; Smalley I; Pina Y
Breast Cancer Res; 2024 Mar; 26(1):55. PubMed ID: 38553702
[TBL] [Abstract][Full Text] [Related]
11. Predicting leptomeningeal disease spread after resection of brain metastases using machine learning.
Tewarie IA; Senko AW; Jessurun CAC; Zhang AT; Hulsbergen AFC; Rendon L; McNulty J; Broekman MLD; Peng LC; Smith TR; Phillips JG
J Neurosurg; 2023 Jun; 138(6):1561-1569. PubMed ID: 36272119
[TBL] [Abstract][Full Text] [Related]
12. Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease.
Law V; Smalley I; Evernden BR; Baldwin M; Smalley KSM; Forsyth PA
J Vis Exp; 2024 Mar; (205):. PubMed ID: 38619274
[TBL] [Abstract][Full Text] [Related]
13. A Case of MRI-Negative Leptomeningeal Disease From Non-small Cell Lung Cancer.
Kokavec A; Laba J
Cureus; 2024 Mar; 16(3):e56727. PubMed ID: 38646403
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
15. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
16. Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
Johnson MD; Avkshtol V; Baschnagel AM; Meyer K; Ye H; Grills IS; Chen PY; Maitz A; Olson RE; Pieper DR; Krauss DJ
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):537-43. PubMed ID: 26867883
[TBL] [Abstract][Full Text] [Related]
17. Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH; Olson JJ; Oyesiku NM; Wait SD; Curran WJ; Shu HK; Prabhu RS
Neurosurgery; 2016 Aug; 79(2):279-85. PubMed ID: 26528673
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery.
Yang TJ; Oh JH; Folkert MR; Gupta G; Shi W; Zhang Z; Morikawa A; Seidman A; Brennan C; Yamada Y; Chan TA; Beal K
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):518-25. PubMed ID: 25194669
[TBL] [Abstract][Full Text] [Related]
19. Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation.
Kim KH; Cho BC; Lee CG; Kim HR; Suh YG; Kim JW; Choi C; Baek JG; Cho J
Technol Cancer Res Treat; 2016 Feb; 15(1):122-9. PubMed ID: 25601853
[TBL] [Abstract][Full Text] [Related]
20. Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA).
Sperduto PW; Shanley R; Luo X; Andrews D; Werner-Wasik M; Valicenti R; Bahary JP; Souhami L; Won M; Mehta M
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):526-31. PubMed ID: 25304947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
